Skip Nav Destination
Issues
1 October 2017
-
Cover Image
Cover Image
JCAD and LATS2 were stained immunohistochemically with specific primary antibodies and secondary antibodies labeled with Alexa-488 (green for JCAD) or Alexa-594 (red for LATS2). The nucleus was visualized by DAPI staining in blue. JCAD is overlaid with LATS2 in the proximity of the nucleus and appears in yellow. For details, see article by Ye and colleagues on page 5287.Close Modal - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0008-5472
EISSN 1538-7445
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Breaking Advances
Review
Meeting Report
New Advances and Challenges of Targeting Cancer Stem Cells
Nurmaa K. Dashzeveg; Rokana Taftaf; Erika K. Ramos; Luke Torre-Healy; Anastasia Chumakova; Daniel J. Silver; Tyler J. Alban; Maksim Sinyuk; Praveena S. Thiagarajan; Awad M. Jarrar; Soumya M. Turaga; Caner Saygin; Erin Mulkearns-Hubert; Masahiro Hitomi; Jeremy N. Rich; Stanton L. Gerson; Justin D. Lathia; Huiping Liu
Priority Report
Molecular and Cellular Pathobiology
A Novel Functional Splice Variant of AKT3 Defined by Analysis of Alternative Splice Expression in HPV-Positive Oropharyngeal Cancers
Theresa Guo; Akihiro Sakai; Bahman Afsari; Michael Considine; Ludmila Danilova; Alexander V. Favorov; Srinivasan Yegnasubramanian; Dylan Z. Kelley; Emily Flam; Patrick K. Ha; Zubair Khan; Sarah J. Wheelan; J. Silvio Gutkind; Elana J. Fertig; Daria A. Gaykalova; Joseph Califano
HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas
Mianen Sun; Pan Tong; Wen Kong; Baijun Dong; Yiran Huang; In Young Park; Lijun Zhou; Xian-De Liu; Zhiyong Ding; Xuesong Zhang; Shanshan Bai; Peter German; Reid Powell; Quan Wang; Xuefei Tong; Nizar M. Tannir; Surena F. Matin; W. Kimryn Rathmell; Gregory N. Fuller; Ian E. McCutcheon; Cheryl L. Walker; Jing Wang; Eric Jonasch
Tumor and Stem Cell Biology
Therapeutics, Targets, and Chemical Biology
Author Choice
Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells
Victor A. Gall; Anne V. Philips; Na Qiao; Karen Clise-Dwyer; Alexander A. Perakis; Mao Zhang; Guy T. Clifton; Pariya Sukhumalchandra; Qing Ma; Sangeetha M. Reddy; Dihua Yu; Jeffrey J. Molldrem; George E. Peoples; Gheath Alatrash; Elizabeth A. Mittendorf
Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors
Jennifer M. Sahni; Sylvia S. Gayle; Bryan M. Webb; Kristen L. Weber-Bonk; Darcie D. Seachrist; Salendra Singh; Steven T. Sizemore; Nicole A. Restrepo; Gurkan Bebek; Peter C. Scacheri; Vinay Varadan; Matthew K. Summers; Ruth A. Keri
Integrated Systems and Technologies
Clinical Studies
Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing
Maria Schwaederle; Ranajoy Chattopadhyay; Shumei Kato; Paul T. Fanta; Kimberly C. Banks; In Sil Choi; David E. Piccioni; Sadakatsu Ikeda; AmirAli Talasaz; Richard B. Lanman; Lyudmila Bazhenova; Razelle Kurzrock
Prevention and Epidemiology
Correction
Advertisement